Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity

BACKGROUND/AIMS: Tumor necrosis factor-α (TNF-α) inhibitors and ustekunimab are widely used in autoimmune diseases. It is known that these biological agents cause the reactivation of hepatitis B virus (HBV). There is no standardized strategy to prevent the reactivation in patients with evidence of a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Turk J Gastroenterol
Main Authors: Solay, Aslı Haykır, Acar, Ali, Eser, Fatma, Kuşcu, Ferit, Tütüncü, Emin Ediz, Kul, Gülnur, Şentürk, Gönül Çiçek, Gürbüz, Yunus
Formato: Artigo
Idioma:Inglês
Publicado em: Turkish Society of Gastroenterology 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6284614/
https://ncbi.nlm.nih.gov/pubmed/30260778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2018.18032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados